Loading...
Correction: brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up
Domingo-Domènech, E. Pro, B. Illidge, T. Horwitz, S. Trumper, L. Iyer, S. Advani, R. Bartlett, N. L. Christensen, J. H. Kim, W. S.
Domingo-Domènech, E.
Pro, B.
Illidge, T.
Horwitz, S.
Trumper, L.
Iyer, S.
Advani, R.
Bartlett, N. L.
Christensen, J. H.
Kim, W. S.
Abstract
Authors
Domingo-Domènech, E.
Pro, B.
Illidge, T.
Horwitz, S.
Trumper, L.
Iyer, S.
Advani, R.
Bartlett, N. L.
Christensen, J. H.
Kim, W. S.
Feldman, T.
Choi, I.
Gritti, G.
Belada, D.
Shustov, A.
Illes, A.
Zinzani, P. L.
Hüttmann, A.
Trneny, M.
Le Gouill, S.
Jagadeesh, D.
Friedberg, J. W.
Little, M.
Dong, C.
Fanale, M.
Fenton, K.
Savage, K. J.
Pro, B.
Illidge, T.
Horwitz, S.
Trumper, L.
Iyer, S.
Advani, R.
Bartlett, N. L.
Christensen, J. H.
Kim, W. S.
Feldman, T.
Choi, I.
Gritti, G.
Belada, D.
Shustov, A.
Illes, A.
Zinzani, P. L.
Hüttmann, A.
Trneny, M.
Le Gouill, S.
Jagadeesh, D.
Friedberg, J. W.
Little, M.
Dong, C.
Fanale, M.
Fenton, K.
Savage, K. J.
Description
Date
2026
Publisher
Collections
Files
Loading...
Found from Unpaywall
Adobe PDF, 370.97 KB
Keywords
Type
Article
Citation
Domingo-Domènech E, Pro B, Illidge T, Horwitz S, Trumper L, Iyer S, et al. Correction: brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up. Blood Cancer Journal. 2026 Jan 28;16(1):21. Epub 2026/01/29.